effective treatments
HGS-OvCa populations
HGS-OvCa tumors
HGS-OvCa patient care
OvCa patients
effective drug combinations
effective combinatorial treatments
existing HGS-OvCa data
ovarian cancer deaths
lack of effective
effective combinatorial targeting of high-grade serous ovarian cancer
individual ovarian cancer patients
single-cell analysis
single-cell level
cell sorting
right patient
inefficient treatments
multiple anatomic sites of HGS
best combination of  drug combination
error clinical assessment of drug combinations
drug screening experiments
right therapeutic regimen
novel treatment
multidisciplinary project
diagnostic modalities
network models
proposed approach
health-care system
long-lasting therapeutic regimens
actionable treatment suggestions
better stratified clinical trials
tools
transcriptomics levels
systematic prediction
fresh sample specimens
predictive biomarker kit
pharmaceutical industry
systems medicine
marked decrease
major breakthrough
developed mass cytometry
number of expensive
subpopulations
goal
current trial
retrospective cohorts
Comprehensive characterization
year
innovative strategy
women
metastatic disease
Europe
way
Fluorescence
key results
HERCULES
advantage
modelling efforts